Literature DB >> 29146601

Airway microbiota across age and disease spectrum in cystic fibrosis.

Edith T Zemanick1, Brandie D Wagner2,3, Charles E Robertson2, Richard C Ahrens4, James F Chmiel5, John P Clancy6, Ronald L Gibson7, William T Harris8, Geoffrey Kurland9, Theresa A Laguna10, Susanna A McColley11, Karen McCoy12, George Retsch-Bogart13, Kurtis T Sobush14, Pamela L Zeitlin15, Mark J Stevens2, Frank J Accurso2, Scott D Sagel2, J Kirk Harris2.   

Abstract

Our objectives were to characterise the microbiota in cystic fibrosis (CF) bronchoalveolar lavage fluid (BALF), and determine its relationship to inflammation and disease status.BALF from paediatric and adult CF patients and paediatric disease controls undergoing clinically indicated bronchoscopy was analysed for total bacterial load and for microbiota by 16S rDNA sequencing.We examined 191 BALF samples (146 CF and 45 disease controls) from 13 CF centres. In CF patients aged <2 years, nontraditional taxa (e.gStreptococcus, Prevotella and Veillonella) constituted ∼50% of the microbiota, whereas in CF patients aged ≥6 years, traditional CF taxa (e.gPseudomonas, Staphylococcus and Stenotrophomonas) predominated. Sequencing detected a dominant taxon not traditionally associated with CF (e.gStreptococcus or Prevotella) in 20% of CF BALF and identified bacteria in 24% of culture-negative BALF. Microbial diversity and relative abundance of Streptococcus, Prevotella and Veillonella were inversely associated with airway inflammation. Microbiota communities were distinct in CF compared with disease controls, but did not differ based on pulmonary exacerbation status in CF.The CF microbiota detected in BALF differs with age. In CF patients aged <2 years, Streptococcus predominates, whereas classic CF pathogens predominate in most older children and adults.
Copyright ©ERS 2017.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29146601      PMCID: PMC5935257          DOI: 10.1183/13993003.00832-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  50 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

2.  Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota.

Authors:  Amanda F Goddard; Benjamin J Staudinger; Scot E Dowd; Amruta Joshi-Datar; Randall D Wolcott; Moira L Aitken; Corinne L Fligner; Pradeep K Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-07       Impact factor: 11.205

3.  Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers.

Authors:  Franziska A Stressmann; Geraint B Rogers; Erich R Klem; Andrew K Lilley; Scott H Donaldson; Thomas W Daniels; Mary P Carroll; Nilesh Patel; Benjamin Forbes; Richard C Boucher; Matthew C Wolfgang; Kenneth D Bruce
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

4.  Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity.

Authors:  Janet G M Markle; Daniel N Frank; Steven Mortin-Toth; Charles E Robertson; Leah M Feazel; Ulrike Rolle-Kampczyk; Martin von Bergen; Kathy D McCoy; Andrew J Macpherson; Jayne S Danska
Journal:  Science       Date:  2013-01-17       Impact factor: 47.728

5.  Investigation of sinonasal microbiome spatial organization in chronic rhinosinusitis.

Authors:  Vijay R Ramakrishnan; Sarah Gitomer; Jennifer M Kofonow; Charles E Robertson; Daniel N Frank
Journal:  Int Forum Allergy Rhinol       Date:  2016-09-14       Impact factor: 3.858

6.  Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.

Authors:  Scott D Sagel; Ronald L Gibson; Julia Emerson; Sharon McNamara; Jane L Burns; Jeffrey S Wagener; Bonnie W Ramsey
Journal:  J Pediatr       Date:  2008-09-25       Impact factor: 4.406

Review 7.  Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.

Authors:  Kamini Jain; Claire Wainwright; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2013-12-23

8.  SINA: accurate high-throughput multiple sequence alignment of ribosomal RNA genes.

Authors:  Elmar Pruesse; Jörg Peplies; Frank Oliver Glöckner
Journal:  Bioinformatics       Date:  2012-05-03       Impact factor: 6.937

9.  Lung microbiota across age and disease stage in cystic fibrosis.

Authors:  Bryan Coburn; Pauline W Wang; Julio Diaz Caballero; Shawn T Clark; Vijaya Brahma; Sylva Donaldson; Yu Zhang; Anu Surendra; Yunchen Gong; D Elizabeth Tullis; Yvonne C W Yau; Valerie J Waters; David M Hwang; David S Guttman
Journal:  Sci Rep       Date:  2015-05-14       Impact factor: 4.379

10.  The microbial community of the cystic fibrosis airway is disrupted in early life.

Authors:  Julie Renwick; Paul McNally; Bettina John; Todd DeSantis; Barry Linnane; Philip Murphy
Journal:  PLoS One       Date:  2014-12-19       Impact factor: 3.240

View more
  67 in total

Review 1.  Past, Present, and Future Research on the Lung Microbiome in Inflammatory Airway Disease.

Authors:  Lindsay J Caverly; Yvonne J Huang; Marc A Sze
Journal:  Chest       Date:  2019-05-30       Impact factor: 9.410

Review 2.  The Yin and Yang of Streptococcus Lung Infections in Cystic Fibrosis: a Model for Studying Polymicrobial Interactions.

Authors:  Jessie E Scott; George A O'Toole
Journal:  J Bacteriol       Date:  2019-05-08       Impact factor: 3.490

Review 3.  Cystic fibrosis respiratory microbiota: unraveling complexity to inform clinical practice.

Authors:  Lindsay J Caverly; John J LiPuma
Journal:  Expert Rev Respir Med       Date:  2018-09-03       Impact factor: 3.772

4.  Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis.

Authors:  Charles R Esther; Marianne S Muhlebach; Camille Ehre; David B Hill; Matthew C Wolfgang; Mehmet Kesimer; Kathryn A Ramsey; Matthew R Markovetz; Ian C Garbarine; M Gregory Forest; Ian Seim; Bryan Zorn; Cameron B Morrison; Martial F Delion; William R Thelin; Diane Villalon; Juan R Sabater; Lidija Turkovic; Sarath Ranganathan; Stephen M Stick; Richard C Boucher
Journal:  Sci Transl Med       Date:  2019-04-03       Impact factor: 17.956

5.  Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study.

Authors:  Marianne S Muhlebach; Joseph E Hatch; Gisli G Einarsson; Stef J McGrath; Deirdre F Gilipin; Gillian Lavelle; Bojana Mirkovic; Michelle A Murray; Paul McNally; Nathan Gotman; Sonia Davis Thomas; Matthew C Wolfgang; Peter H Gilligan; Noel G McElvaney; J Stuart Elborn; Richard C Boucher; Michael M Tunney
Journal:  Eur Respir J       Date:  2018-07-11       Impact factor: 16.671

6.  Differences in the lower airway microbiota of infants with and without cystic fibrosis.

Authors:  Katherine B Frayman; Kristine M Wylie; David S Armstrong; Rosemary Carzino; Stephanie D Davis; Thomas W Ferkol; Keith Grimwood; Gregory A Storch; Sarath C Ranganathan
Journal:  J Cyst Fibros       Date:  2018-12-21       Impact factor: 5.482

7.  Age and environmental exposures influence the fecal bacteriome of young children with cystic fibrosis.

Authors:  Brett R Loman; Chandra L Shrestha; Rohan Thompson; Judith A Groner; Asuncion Mejias; Kathryn L Ruoff; George A O'Toole; Michael T Bailey; Benjamin T Kopp
Journal:  Pediatr Pulmonol       Date:  2020-04-10

Review 8.  Methods in Lung Microbiome Research.

Authors:  Sharon M Carney; Jose C Clemente; Michael J Cox; Robert P Dickson; Yvonne J Huang; Georgios D Kitsios; Kirsten M Kloepfer; Janice M Leung; Tricia D LeVan; Philip L Molyneaux; Bethany B Moore; David N O'Dwyer; Leopoldo N Segal; Stavros Garantziotis
Journal:  Am J Respir Cell Mol Biol       Date:  2020-03       Impact factor: 6.914

9.  Cooperativity between Stenotrophomonas maltophilia and Pseudomonas aeruginosa during Polymicrobial Airway Infections.

Authors:  Melissa S McDaniel; Trenton Schoeb; W Edward Swords
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

10.  Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.

Authors:  J Kirk Harris; Brandie D Wagner; Edith T Zemanick; Charles E Robertson; Mark J Stevens; Sonya L Heltshe; Steven M Rowe; Scott D Sagel
Journal:  Ann Am Thorac Soc       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.